ABSTRACT
INTRODUCTION
A number of specific chromosomal translocations are uniquely associated with morphologically and clinically well-defined human malignant diseases, e.g., t(9;22) translocation with chronic myelogenous leukemia and t(14;18) translocation with follicular lymphoma. These translocations have been thought to represent crucial primary events in tumorigenesis, and the underlying molecular changes were believed to be specific for tumor cells. Since the DNA sequences located at the breakpoints of several recurring translocations have been analyzed in detail, the resulting fusion genes or their products can be tested at the DNA or RNA level. Polymerase chain reaction (PCR) techniques have been widely used as diagnostic tools (14) . In addition to the identification of tumors associated with certain specific chromosomal translocations, follow-up studies to detect minimal residual tumor cells by PCR have been carried out to obtain prognostic information.
The sensitivity of most PCR assays carried out with genomic DNA is one positive cell in 10 5-6 normal cells, and it can reach one in 10 7 normal cells if stochastic analyses are included. By increasing the sensitivity of the PCR technique, the situation has been complicated; up to 50% of healthy blood donors have been found to carry circulating t(14;18)-positive cells that seem to be long-lived (3, 9, 11, 12) . In addition, circulating bcr-abl mRNA positive cells have also been detected in normal individuals with no evidence of chronic myelogenous leukemia (1) . The literature contains contradictory reports as to the prognostic implications of detection of the t(14;18) translocation. For instance, it has been reported that minimal numbers of residual t(14;18)-positive cells carrying the same translocation as the initial lymphoma cells have been detected by PCR in longterm remission 10-15 years after successful radiotherapy, which seems to be compatible with cure (5, 13) . On the other hand, circulating t(14;18)-positive cells consistently detected by PCR during the first 5 years after treatment for relapse seem to indicate again a high risk for relapse (6) . Therefore, quantitative results might help to gain more prognostic information in research on minimal residual disease (MRD) detected by PCR analysis of circulating blood cells, bone marrow cells and autologous blood stem-cell preparations used for transplantation after high-dose chemotherapy.
Here, we describe an automated PCR technique based on the use of double-labeled fluorogenic probes to quantitate t(14;18)-positive cells in real time. The present work was done to develop a highly sensitive and reproducible quantitative PCR technique for the detection of t(14;18)-positive cells that allows for screening large series in clinical and epidemiological studies.
MATERIALS AND METHODS

DNA Samples
The human B-cell lymphoma line Karpas 422 (4) Cambridge, UK). This cell line carries a t(14;18) translocation with a breakpoint in the major breakpoint region (MBR) of the bcl -2 gene and served as a positive control. DNA prepared from the Burkitt's lymphoma cell line Raji and human placenta were used as negative controls. Peripheral blood samples were obtained from patients with malignant follicular lymphoma. Mononuclear cells were isolated from peripheral blood by Ficoll-Hypaque ® (Amersham Pharmacia Biotech, Freiburg, Germany) centrifugation. High-molecular-weight DNA (HMW-DNA or "spooled" DNA) was prepared by standard proteinase K digestion, phenol/chloroform-extraction and ethanol-precipitation. DNA concentration was determined spectrophotometrically. The samples were stored in aliquots at -20°C.
Standard PCR
Our standard protocol used for the amplification of bcl -2-MBR/Ig H -rearrangements by a two-step, semi-nested PCR has been described (3, 5) . PCR was performed in a total volume of 100 µ L containing 10 mM Tris-HCl, pH 8.3, 50 mM KCl, 1.5 mM MgCl 2, 100 µ g/ mL gelatin, 0.2 µ M each dNTP, 0.6 µ M each primer, 2 U of TaqDNA Polymerase (AmpliTaq ® ; PE Applied Biosystems, Weiterstadt, Germany) and varying amounts of cellular DNA up to 1 µ g for 30 cycles in a DNA Thermal Cycler 480 (PE Applied Biosystems). After an initial denaturation step at 94°C for 7 min, the PCR cycle conditions were as follows: annealing for 1 min at 55°C, extension for 3 min at 72°C and denaturation for 1 min at 94°C. For the second-step PCR, 10 µ L of the product of the first PCR were subjected to amplification for another 30 cycles. In all experiments, appropriate negative controls containing no template DNA were subjected to the same procedure to exclude or detect any possible contamination or carryover. The oligonucleotides were synthesized with a Model 380A Oligonucleotide Synthesizer (PE Applied Biosystems) and precipitated by ethanol before use. In the two-step PCR, one universal J H primer (A): 5 ′ -ACCT -GAGGAGACGGTGAC-3 ′ was used in combination with an "inner" BCL-2 primer (B): 5 ′ -TGGGGTTTTGACCT -TTAGAGA-3 ′ and an "outer" BCL-2 primer (C): 5 ′ -GAACAGAATGATCA-GAGCCT-3 ′ . One-tenth of the reaction volume was analyzed on 2% agarose gels. DNA was stained with ethidium bromide and transferred to Gene Screen ® Plus Nylon Membranes (NEN Life Science Products, Boston, MA, USA) by alkaline transfer. Hybridization was performed overnight at 42°C using a 32 P-labeled internal 18q-oligonucleotide (5 ′ -CACAGACCCACCCA-GAGCCC-3 ′ ). The filters were washed under stringent conditions for 15 min at 65°C, twice with 3 × SSC, once with 1 × SSC and finally with 0.1 × SSC (1 × SCC = 0.15 mol/L sodium chloride, 0.015 mol/L sodium citrate, pH 7.0). Autoradiography was performed at -70°C with intensifying screens.
Limiting Dilution Assay
HMW-DNA was diluted with water and added to the PCR mixtures at the following final amounts: 1.0, 0.1, 0.01 and 0.001 µ g and, if necessary, at further 10-fold dilutions. In the case of negative samples, standard PCR experiments were carried out with 10, 5, 2.5 and 1 µ g DNA. One microgram of human genomic DNA corresponds to about 140 000 mononuclear cells.
Multiple-Tube Approach
The number of t(14;18)-positive cells was also determined by the "multiple-tube approach" based on Poisson assumptions using DNA in amounts giving positive and negative results upon repetitive testing (3). If 10 µ g DNA of a certain sample gave a negative result by standard PCR, the assay was repeated with 3-5 replicates of 10 µ g DNA; alternatively, in some cases, the assay was repeated 10 ×with 2 µ g DNA depending on the total DNA amount available. If all test tubes containing a certain amount of DNA were found to be positive by PCR, the assay was repeated with DNA samples further diluted.
Real-Time Quantitative PCR
Based on the 5 ′ nuclease activity of TaqDNA polymerase (8), PCR amplification in the presence of target-specific, double-labeled fluorogenic probes (10) allows an automated quantitation of the amplification products in real time using the ABI PRISM ™ 7700 Sequence Detection System (PE Applied Biosystems). For the detection of the t(14;18) translocation by this technique, we used a one-step PCR amplification with the J H -consensus primer (A) and the inner BCL-2 primer (B). As the probe, we have chosen a 25-bp oligonucleotide that includes the sequence of the 18q detection oligonucleotide of the two-step PCR: 5 ′ -CT -CTGGGTGGGTCTGTGTTGAAACA -3 ′ . The 5 ′ -and 3 ′ -end nucleotides of this probe were labeled with a reporter (FAM = 6-carboxy-fluorescein) and a quencher dye (TAMRA = 6-carboxytetramethylrhodamine). All labeled probes (TaqMan ™ Fluorogenic Probes) were synthesized by PE Applied Biosystems. The PCR mixture contained 400 nM of each forward and reverse primer, 4 mM MgCl 2 (after optimization), 200 µ M dATP, dCTP and dGTP, 400 µ M dUTP, 1.25 U AmpliTaq Gold ™ , 0.5 U AmpErase ™ UNG (uracil-N-glycosylase) and 1 × PCR Buffer II [50 mM KCl, 10 mM Tris-HCl, pH 8.3, including 60 nM ROX (6-carboxyx-rhodamine = fluorescence reference dye) in a total volume of 50 µ L]. All reagents were obtained from PE Applied Biosystems (TaqManPCR Reagent Kit). The PCR was performed in MicroAmp ® reaction tubes placed in the 96-well rack of the ABI PRISM 7700 Sequence Detection System. After 2-min incubation at 50°C to allow for UNG cleavage, AmpliTaq Gold was activated by an incubation for 10 min at 95°C. Each of the 50 PCR cycles consisted of 15 s denaturation at 95°C and hybridization of probe and primers as well as DNA synthesis for 1 min at 61°C. All intact probe molecules show quenching of the reporter fluorescence. During PCR amplification, increasing numbers of probe molecules hybridize to the specific templates generated. The 5 ′ nuclease activity of TaqDNA polymerase cleaves any double-labeled fluorogenic probe bound to the corresponding DNA strand and releases free reporter molecules. The increase in fluorescence intensity due to increasing numbers of unquenched reporter molecules can be measured in real time, yielding an amplification plot: product synthesized vs. cycle number. Initial copy numbers can be calculated from the time point (cycle number) when the PCR product has first been detected compared with measurements taken during cycles 3-15. This time point is a fractional cycle number (C T = threshold cycle) at which the fluorescence intensity measured has reached a fixed threshold baseline (7) . As a reference, we have used the β -actingene. The specific primers and a labeled probe for the detection of β -actinare provided with the TaqMan PCR Reagent Kit.
The PCR product of each gene under study was cloned using the TA Cloning ™ Kit with pCR ™ II (Invitrogen, Leek, The Netherlands). Recombinant plasmid DNA was isolated by using the QIAprep ® Spin Plasmid Kit (Qiagen, Hilden, Germany). Purified plasmid DNA was digested with Hin d -III, purified again by phenol/chloroform treatment and precipitated by ethanol to be used as a positive standard. Plasmid DNA concentration was determined spectrophotometrically. Appropriate dilutions of these DNA preparations stored at -20°C served as positive controls and reference standards in quantitative PCR assays.
RESULTS
Based on a two-step, semi-nested PCR for the detection of t(14;18)-MBR translocations on genomic DNA, we developed a quantitative one-step PCR using a double-labeled fluorogenic probe. The amplification can be evaluated in real time using the ABI PRISM 7700 Sequence Detection System. The two inner primers of the two-step, semi-nested PCR were used in combination with an oligonucleotide probe of 30 bp complementary to the bcl -2 sequence. The orientation of the probe allows a cleavage by the exonuclease activity of TaqDNA polymerase only when DNA synthesis is primed by the J H antisense primer. Figure 1A shows a typical amplification plot with the cloned t(14;18)-DNA fragment derived from Karpas 422. Depending on the initial copy number (16 000 down to 2), the threshold cycle (C T -value) increases. With low copy numbers ( < 4), the first positive results were observed after 36 cycles. Several negative controls gave negative results even after 50 rounds of amplification. Figure 1B shows the correlation between initial t(14;18) copy numbers and C T -values when genomic Karpas 422 DNA or the cloned t(14;18) DNA fragment was tested. The detection of a single copy present in appropriately diluted samples of Karpas 422 DNA could be verified by the multiple-tube approach, with DNA samples further diluted containing less than 1 copy per assay (see insert in Figure 1B , which shows the data of a representative experiment). The t(14;18) DNA fragment amplified from Karpas 422 was cloned and used as the final standard for quantitative analyses. It is generally thought to be a "better" standard than genomic human DNA because of large amounts of welldefined standard molecules with no interference of pseudogenes can be isolated once and stored in aliquots in the presence of a stabilizing, well-characterized carrier DNA. To ensure efficient denaturation in quantitative PCR experiments, the recombinant plasmid DNA had to be linearized by restriction enzyme digestion with Hin dIII, and the DNA was purified again. This plasmid DNA was used in several experiments to establish standard curves. Tests with different DNA preparations gave different but parallel regression lines, when the DNA content was based on spectrophotometric measurements of the purified restricted recombinant plasmid DNA. Using the stochastic multipletube approach with two-fold dilutions up to 1/8 copy per assay, the copy numbers present in different standard plasmid preparations had to be corrected by a factor of 4-8. After the correction, the standard regression lines obtained with genomic DNA and the cloned DNA fragment were almost identical ( Figure  1B) . The results are highly reproducible with initial copy numbers in the range between 10 5 and 5-10. Repetitive testing of frozen aliquots of a positive standard containing 100 copies gave a mean C T of 30.54, with a lower and upper 95% confidence interval of 30.1 and 30.97, i.e., within one cycle. Greater variations in C T values are found in experiments with initial copy numbers below 3-5. Therefore, stochastic multiple-tube assays should be carried out with samples containing presumably 2-4 and less copy numbers. Since a sample containing only one copy (C T 37-40) can be very well distinguished from a negative one (C T >50), single copies can be detected. From the data shown in Figure 1B , it can be calculated that a twofold increase in copy numbers leads to a decrease of C T values by one step, i.e., one amplification cycle.
Since the assay was established to quantitatively analyze lymphoma or tumor tissue, peripheral blood cells, bone marrow cells and blood stem-cell preparations for t(14;18)-positive cells, clinical samples already analyzed by our standard PCR technique were studied for comparison. PBMNC obtained from 10 patients with follicular lymphoma that had 1 positive cell in 10-100 000 negative cells as determined by limiting dilution assays were tested by real-time quantitative PCR using 2-7 twofold dilution steps of isolated DNA (Figure 2 ). t(14;18) copy numbers ["t(14;18)-positive cells"] present in these samples were then calculated based on positive standards. The quantitative determinations shown in Figure  2 were based on the spectrophotometric determination of high-molecularweight ("spooled") DNA isolated from PBMNC. The highest DNA amount used in real-time quantitative PCR was 1 µ g/50 µ L assay, since higher amounts showed inhibitory effects that can be easily observed and documented by this technique (results not shown).
During a clinical and molecular follow-up study, 71 PBMNC samples were obtained from 16 patients with t(14;18)-positive follicular lymphoma in complete remission after radiotherapy for low-stage disease. The samples had already been tested by a limiting dilution assay combined with a two-step, seminested PCR followed by Southern blot hybridization. Figure 3 shows the results of this comparative analysis on 51 positive samples; the results correlate quite well. Nineteen samples being negative by standard PCR were also negative by real-time quantitative PCR, and only one previously negative sample was positive by real-time quantitative PCR using the multiple-tube approach This is a plot of initial copy numbers against the threshold cycle (C T ), i.e., a time point or a fractional cycle number when the first significant fluorescence intensity above background has been observed. The results of the stochastic multiple-tube approach with genomic Karpas 422 DNA (shown on the right) are compatible with the spectrophotometric DNA determination based on the assumption that 1 µg DNA corresponds to about 140 000 cells. In the case of the cloned DNA fragment, the results of this approach were used to correct OD measurements for the content of amplifiable DNA. Finally, after this correction, the regression lines with both standard DNAs are almost identical.
(1+/320 000; results not shown).
Since many DNA samples have been frozen and thawed at least twice, all DNA samples were also tested for β -actinby real-time quantitative PCR. Based on optical density (OD) measurements, DNA samples adjusted to contain about 60 000 copies/assay were tested three times. The copy numbers of β -actinwere calculated from standard curves prepared with genomic Raji cell DNA and a cloned β -actin DNA fragment. Correcting the data shown in Figure 3 for their relative content of β -actincopies did not alter the results and their interpretation (results not shown). Limited degradation of DNA might have occurred only in a very few samples during repetitive freezing and thawing.
DISCUSSION
Many commonly used quantitative PCR techniques are believed to yield only semiquantitative results. Competitive PCR seems to be reliable although very labor-intensive, with a high risk of introducing carryover. This paper describes an automated, very sensitive, highly reproducible real-time quantitative PCR for the detection of t(14;18)-positive cells in lymphoma tissue, PBMNC, bone marrow aspirates and peripheral blood stem-cell preparations. Using a double-labeled fluorogenic probe, the increase of specific amplification products can be monitored in real time by the ABI PRISM 7700 Sequence Detection System. Since there is a strong correlation between the initial copy number and the so-called threshold cycle C T ( Figure  1A and B), quantitative results can be obtained in relation to positive standards. The reproducibility of repetitive tests on the same DNA is excellent, the greatest variation in larger series is introduced by pipetting, the determination of the DNA concentration and the "history" of the DNA. OD measurements of human genomic DNA seem to work fine when carried out on HMW-DNA stored at -20°C (Figure 3) . Relative quantitative determinations of a reference gene (cf. β -actin ) can be used to correct for possible contaminations with nucleotides and RNA as well as for limited degradation of DNA. This has been shown by a comparative analysis of the number of circulating t(14;18)-positive cells in relation to the total number of cells studied either based on OD measurement or on realtime quantitative PCR for β -actin(results not shown). The spectrophotometric quantitation of a purified, restricted and repurified plasmid DNA to be used as a positive reference is less reliable compared with genomic DNA, presumably due to limited degradation inspite of all precautions taken. Therefore, the DNA content of the plasmid DNA preparations was controlled by limiting dilution combined with the stochastic multiple-tube approach ( Figure 1B standards containing between 10 and 10 5 copies lead to limited degradation detectable by quantitative PCR and a reduction of copy numbers by a factor up to 10 could be found (results not shown). Therefore, small aliquots of positive standards are now being stored in the presence of 0.1-0.5 µ g carrier DNA (cf. salmon sperm DNA). Repetitive testing of positive samples kept frozen in small aliquots at -20°C gave highly reproducible results. In addition, samples of linearized recombinant plasmid DNA gave C T values 3-5 cycles lower than samples containing circular plasmid DNA inspite of equal copy numbers of t(14;18)-DNA fragments. This indicates that linearizing plasmid DNA by restriction digest is of great importance to facilitate strand separation during heat denaturation.
In the past, we were unable to detect t(14;18)-positive cells by a standard single-step PCR in most of the samples investigated during this study, except the highly positive ones. Therefore, the two-step, semi-nested PCR was introduced. PBMNC obtained from patients with follicular lymphoma were comparatively analyzed for t(14;18)-positive cells by limiting dilution assays combined with a two-step, semi-nested PCR and by real-time quantitative PCR. These experiments (Figure 3) and serial follow up studies on single patients showed that the quantitative results obtained by both assays correlate quite well. Considering that limiting dilution assays (as they were carried out here) are thought to be rather semiquantitative, this correlation is remarkable. In addition, relapses in two patients were proceeded or accompanied by a logarithmic increase in circulating t(14;18)-positive cells; whereas, six patients in continous complete remission for even Real-time quantitative PCR has several advantages compared with the standard two-step, semi-nested PCR combined with a limiting dilution assay, including: there are no critical pipetting steps of amplified products necessary unless an electrophoretical analysis is wanted for special reasons, and the whole procedure is less time-consuming. The sensitivity of real-time quantitative PCR is at least as high as the twostep PCR. But since it is a single-step PCR, UTP and UNG can be used to control contamination due to carryover. The higher specificity of amplification by real-time quantitative PCR has been demonstrated by an electrophoretical analysis of the amplification products of both PCR techniques using the same sample DNA. In the case of the twostep PCR, many additional DNA fragments are amplified even in the presence of substantial amounts of a specific t(14;18) DNA fragment; whereas, the Southern blot analysis of the product of real-time quantitative PCR showed one specific DNA fragment only. The use of UTP/UNG and of heat-activated AmpliTaq Gold DNA Polymerase variant enzyme ("hot start") and improved hybridization conditions for primers in the presence of an optimized MgCl 2 concentration might explain the higher specificity.
Quantitative PCR analyses by realtime quantitative PCR might help to investigate and better understand the meaning of MRD in patients with follicular lymphoma and other tumors carrying genetic alterations detectable by PCR. The results will help us to develop new strategies to detect and remove contaminating tumor cells from blood stem-cell preparations and to initiate novel clinical studies based on molecular-defined disease. In addition, the quantitative determination of a reference gene, like β -actin , allows estimation for any sample, at least a relative and maybe also an absolute sensitivity achieved by real-time quantitative PCR. This again will allow a more precise evaluation of MRD, and results obtained in different laboratories can easily be compared and analyzed.
